Research on China Anesthetic Industry , 2015

40 pages report Published in
Pharmaceuticals
Publisher: Chisult Insight

arrowFor This Report

With the increasing numbers of domestic surgeries, the market size of Chinese anesthetic also increased a lot. The market size of Chinese anesthetic industry reached nearly RMB 6400 million in 2014, increased by 18.8% from a YoY base. Among which, General anesthesia accounts for around 69% of the total market size.

The competition of anesthetic in China is steady. High-end market is dominated by oligopoliesm, which maintained the increase level of the industry. Overall, anesthetic market in China is dominated by foreign and affective domestic companies.

Propofol takes the largest amount of usage in Chinese intravenous anesthetic market, the market size is around 770 million in 2014.AZN is the largest supplier of propofol in China, Fresenius ranks the sencond.Due to the fierce competition status, the growth of propofol will probably slow down.

As for narcotic analgesics market,fentanyl category products is the leader. Humanwell accounts for most of the market share of fentanyl injection market,and Xian Janssen is the leader in fentanyl transdermal patches.Xianju Pharma’s fentanyl transdermal patches have came into market in 2013, but till now the product have not contribute any profit.

In muscle relaxant market, currently there are 4 companies obtained the product approval of cisatracurium.Heng Rui Medicine Co., Ltd accounts for 56% of cisatracurium market, Sino biopharma ranks second with a market share of over 30%.

Table of Contents

1 Introduction
1.1 Definition
1.2 Structure

2 Overview of Chinese Anesthetic Industry

3 Market Segments
3.1 General Anesthetics
3.1.1 Inhalation Anesthetic
3.1.2 Intravenous Anesthetic
3.1.2.1 Propofol
3.1.2.2 Etomidate
3.1.2.3 Midazolam
3.1.2.4 Dexmedetomidine
3.2 Local Anesthetic
3.3 Narcotic Analgesics
3.3.1 Morphine
3.3.2 Fentanyl
3.3.3 Oxycodone
3.4 Muscle Relaxant

4 Competitiveness Analysis

5 Major Enterprises
5.1 Yichang Humanwell Pharmaceutical Co., Ltd.
5.1.1 Company Profile
5.1.2 Key Financial Data
5.1.3 Anesthetic Business
5.2 Jiangsu Heng Rui Medicine Co., Ltd.
5.2.1 Company Profile
5.2.2 Key Financial Data
5.2.3 Anesthetic Business
5.3 Jiangsu Nhwa Pharmaceutical Co., Ltd
5.3.1 Company Profile
5.3.2 Key Financial Data
5.3.3 Anesthetic Business
5.4 Xianju Pharma
5.4.1 Company Profile
5.4.2 Key Financial Data
5.4.3 Anesthetic Business
5.5 Henan Lingrui Pharmaceutical Co., Ltd.
5.5.1 Company Profile
5.5.2 Key Financial Data
5.5.3 Anesthetic Business

6 Industry Main Indicators

List of Charts

Differences between general anesthesia and local anesthesia
Classification of anesthesia
Numbers of surgery among in-patients in China, 2007-2014
Market size of anesthetic in China, 2010-2014
Market share of general anesthesia and local anesthesia in China, 2014
2010-2014 Market Size of General Anesthetics in China
2014 Market Share of Inhalation Anesthetic and Intravenous Anesthetics in China
Comparison of common inhalation anesthetic
2014 Market share of various kinds of inhalation anesthetic
2010-2014 Market size of inhalation anesthetic in China by products
Manufacturers/ ceiling price and medical insurance of common inhalation anesthetic in China
Bidding price of sevoflurane in China by enterprises
2014 Market share of sevoflurane in China
2010-2014 Market size of intravenous anesthetic in China by products
2014 Market share of propofol in China by companies
2010-2014 Sales of propofol in China
List of enterprises with etomidate products in China
Bidding price of etomidate by regions in China
2014 Market share of etomidate in China by companies
List of enterprises with midazolam products in China
Bidding price of midazolam by regions in China
2014 Market share of midazolam in China by companies
List of enterprises with midazolam products in China
2014 Market share of dexmedetomidine in China by companies
Bidding price of midazolam by regions in China
Development history of local anesthetic
Classification of local anesthetic
2014 Market share of local anesthetic in China by products
2014 Market share of levobupivacaine in China by products
Production and distribution status of narcotic analgesics in China
2014 Demand volume of narcotic analgesics by country
2014 Market share of narcotic analgesics in China by products
Control types and market size of narcotic analgesics in China by products
Morphine related products and manufacturers in China
2014 market share of morphine related preparations in China by enterprises
Fentanyl related products and manufacturers in China
Medical insurance status of fentanyl related products in China
2014 Market share of fentanyl injection in China by enterprises
2014 Market share of fentanyl transdermal patches in China by enterprises
2014 Market share of sufentanil in China by enterprises
2014 Market share of remifentanil in China by enterprises
2010-2014 Sales of remifentanil in China
2010-2014 Sales of sufentanil in China
Enterprises licensed for production of oxycodone in China
2010-2014 Sales of Oxycodone sustained-release tablets in China
Comparison of common muscle relaxant in China
2014 Market share of muscle relaxant in China by products
Manufacturers of atracurium and cisatracurium in China
Bidding price of atracurium and cisatracurium in China
2010-2014 Sales of atracurium in China
2014 Market share of cisatracurium in China by enterprises
2014 Market share of Vecuronium Bromide in China by enterprises
Manufacturers of rocuronium bromide in China
2014 Market share of rocuronium bromide in China by enterprises
Competitiveness Comparison of Major Anesthetic Manufacturers in China
Anesthetic business scope of Major Manufacturers in China
Product line of Yichang Humanwell
2012-2014 Anesthetic revenue of Yichang Humanwell
2012-2014 Market share of fentanyl of Yichang Humanwell by products
2010-2014 Revenue of narcotic analgesics of Heng Rui
2014 Revenue structure of Heng Rui’s Anesthetic products
Anesthetic under R & D of Heng Rui
2010-2014 Revenue structure of Nhwa
2010-2014 Gross profit structure of Nhwa
2010-2014 Revenue of Ehwa’s anesthetic
2005-2014 Sales and growth of Xianju’s rocuronium
2005-2014 Sales and growth of Xianju’s Cisatracurium
2005-2014 Sales and of Xianju’s Vecuronium
2006-2014 Revenue of Xianju’s anesthesia medicine and muscle relaxant

Related Reports

  • China Chemical Pharmaceutical Industry Report, 2013-2016Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than that of the API over the same period. In 2013, China chemical drug preparation industry and and China API industry recorded revenue of RMB 573.1 billion and RMB 382 billion, with gross margin of 35%-40% and 20%, respectively. China is a big producer of chemical APIs, capable of producing […]
  • Research on China Diagnostic Reagent Industry, 2015After 30 years of development, the China's diagnostic reagent industry achieved a market size of nearly RMB 20 billion in 2014, a YoY growth of 15.7%. Currently nearly 90% downstream users of China's diagnostic reagent market comes from hospitals. There's still a huge growth potential in China's diagnostic reagent industry. China accounts for 20% of total population worldwide, but only take up 7% of global diagnostic reagent market in 2014. The average diagnostic reagent expense […]
  • Janssen Pharmaceuticals, Inc. – Product Pipeline Review – 2014Global Markets Direct's, ‘Janssen Pharmaceuticals, Inc. Product Pipeline Review 2014', provides an overview of the Janssen Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Janssen Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and […]
  • China Hemodialysis Industry Research Report, 2015Counting by theoretic morbidity, currently there are nearly 2000 thousand people in China with terminal nephropathy. If all these patients receive dialysis treatment, the market size of dialysis in China will exceed RMB 100 billion on a cost per patient of RMB 75.1 thousand presently. But actually currently only 15% of these patients received dialysis treatment, where the capacity of the market is still so huge. In March 2014, the NHFPC of China released the ‘Ask for comment on […]
  • Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice (2014 Edition)China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion. On the Chinese healthcare market, imported drugs made by overseas […]